Amid the firestorm of controversy surrounding Cerebral’s alleged improper telehealth prescribing of ADHD pills, some experts view virtual prescribing tools that provide standardized patient assessments as a way to separate bad actors and build support for continued prescribing of controlled substances by legitimate telehealth providers after the pandemic ends.
Inside TeleHealth
Log in to access this content.
Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.
© 2002-2022. Inside Washington Publishers | Contact Us